Skip to content

Weight-adjusted effective volume of 0.5% ropivacaine for costoclavicular-cervical plexus blocks undergoing arthroscopic shoulder surgery: a dose-finding study

Weight-adjusted effective volume of 0.5% ropivacaine for costoclavicular-cervical plexus blocks undergoing arthroscopic shoulder surgery: a dose-finding study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090292
Enrollment
Unknown
Registered
2024-09-26
Start date
2024-10-08
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rotator cuff tears

Interventions

CCB-CPBs Group:According to the upper and lower sequential method, the capacity was varied by 0.5 ml/kg increment or reduction, as determined by the response of the previous subject.

Sponsors

Ningbo No.6 Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1: American Society of Anesthesiologists physical status?-? 2: 18–75 years of age 3: body mass index between 18 and 30 kg/?

Exclusion criteria

Exclusion criteria: 1.Allergy to amide-like local anesthetics 2.Nerve injury or sensory abnormalities 3.History of surgery in the subclavian fossa 4.Have eding tendency or coagulopathy 5.Infection at the puncture site 6.Mental, speech, or hearing impairment

Design outcomes

Primary

MeasureTime frame
NRS scores;

Secondary

MeasureTime frame
Diaphragmatic mobility was assessed using the ultrasound M mode;Intraoperative fentanyl consumption;Implementation time of the nerve block;Adverse nerve block effects (vascular puncture, paresthesia, hoarseness, Horner syndrome, and local anesthetic intoxication);Adverse opioid reactions (postoperative nausea, vomiting or pruritus);

Countries

China

Contacts

Public ContactMiao Zhu

Ningbo No.6 Hospital

zhumiao002@163.com+86 574 8799 6056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026